THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB

Mariangela Allocca  ¹     Gaia Catalano  ¹     Edoardo Vincenzo Savarino  ²     María Chaparro  ³     Asaf Levartovsky     Georgios Michalopoulos     Nikos Viazis     Fotios Fousekis     Andreas Psistakis     Daniele Noviello     Catarina Neto do Nascimento     Bénédicte Caron     Vassiliki Kitsou     Giorgos Bamias     María José García     Eirini Zacharopoulou     Kalliopi Foteino    
¹ IRCCS Hospital San Raffaele and University Vita-Salute San Raffaele, Milan, Italy
² University of Padua, Division of Gastroenterology, Padua, Italy
³ Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Univer

Session
Real world evidence in IBD

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)